Department of General and Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, 227-8501, Japan.
Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Teikyo University Chiba Medical Center, Chiba, Japan.
Surg Today. 2021 Mar;51(3):374-383. doi: 10.1007/s00595-020-02097-1. Epub 2020 Aug 9.
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can achieve marked future liver remnant (FLR) hypertrophy but this procedure is associated with a risk of mortality due to liver failure because of an insufficient FLR functional increase, a situation comparable to small-for-size syndrome (SFSS) after living-donor liver transplantation (LDLT).
The clinical data, morphologic volume changes, and histopathologic and immunohistochemical findings in hepatocytes and bile ductules were compared between ALPPS (n = 10) and LDLT with a risk for SFSS (n = 12).
Although the patient characteristics and short-term outcome differed between the groups, the mean hypertrophy ratios with respect to liver volume for the FLR after performing the first-stage ALPPS procedures resembled those in small-for-size grafts after similar time intervals: 1.702 ± 0.407 in ALPPS vs. 1.948 ± 0.252 in LDLT (P = 0.205). The histologic grades for sinusoidal dilation (P = 0.896), congestion (P = 0.922), vacuolar change (P = 0.964), hepatocanalicular cholestasis (P = 0.969), and ductular reaction (P = 0.728) within the FLR at the second-stage operation during ALPPS or implanted graft were all similar between the groups.
The hepatic regenerative process may be similar in ALPPS and LDLT using a small-for-size graft. Reducing the hepatic vascular inflow that may be excessive for the FLR volume during the first stage of ALPPS might enhance the functional recovery since measures with a similar effect appear to lessen the likelihood of SFSS.
联合肝脏离断和门静脉结扎的分阶段肝切除术(ALPPS)可实现显著的未来肝脏残留(FLR)肥大,但由于 FLR 功能增加不足,该手术与肝功能衰竭相关的死亡率风险相关,这种情况类似于活体供肝移植(LDLT)后的小肝综合征(SFSS)。
比较了 ALPPS(n=10)和 LDLT 中具有 SFSS 风险(n=12)的临床数据、形态体积变化以及肝细胞和胆管的组织病理学和免疫组织化学发现。
尽管两组患者的特征和短期结果不同,但在进行第一阶段 ALPPS 手术后,FLR 的肝体积平均肥大率与类似时间间隔后小供肝移植后的相似:1.702±0.407 在 ALPPS 中与 1.948±0.252 在 LDLT 中(P=0.205)。ALPPS 中第二阶段手术或植入供体时,FLR 中窦状扩张(P=0.896)、充血(P=0.922)、空泡改变(P=0.964)、胆小管胆汁淤积(P=0.969)和胆管反应(P=0.728)的组织学分级在两组之间均相似。
在使用小体积供肝的 ALPPS 和 LDLT 中,肝再生过程可能相似。减少第一阶段 ALPPS 中可能超过 FLR 体积的肝血管流入可能会增强功能恢复,因为具有类似效果的措施似乎会降低 SFSS 的可能性。